In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
from NYT > Health https://ift.tt/nM3R89A
Subscribe to:
Post Comments (Atom)
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing... -
Unusual opioids are infiltrating street drugs. Knoxville’s top forensic doctor is on the front lines, pressing to quickly identify the most ...
-
A long stay in intensive care can bring physical, cognitive and mental health challenges that can take months or longer to resolve. from N...
No comments:
Post a Comment